Wittington Ventures Research
Investment Thesis
Wittington Ventures is the venture capital and growth equity investment platform of Wittington Investments, the holding company of the Weston group (Loblaw, Shoppers Drug Mart, Choice Properties, Holt Renfrew, Joe Fresh, PC Financial, PC Optimum, Lifemark, and others). The firm partners with founders and operators from company creation through first revenue to scaled growth, investing at seed, venture, and growth-equity stages as a single connected platform rather than separate funds. Wittington concentrates on sectors where its affiliated operating businesses and philanthropic organizations (including the Weston Family Foundation) give it genuine strategic insight: commerce, consumer, healthcare, climate, and food. The firm describes its edge as combining investment capital with a broader operating and philanthropic ecosystem, providing portfolio companies access to real operating environments, industry expertise, customers, and distribution networks that most financial-only investors cannot offer.
Stage Focus
Wittington organizes its capital into three connected strategies: Innovation Investing (earliest-stage company creation and direct investment in breakthrough science, often partnering with researchers and institutions to build companies from scratch), Venture Capital (early-to-mid-stage companies establishing market leadership, seed through Series B), and Growth Capital (profitable or near-profitable companies at inflection points, often the final institutional capital before a company transitions to durability). Confirmed portfolio rounds span seed ($2M, Filament), Series A ($78M, Arcaea; ~Series A-1, Abridge), Series B ($25M, Odaia; $40M, Noetik; $40M, Doctronic), and growth-stage consumer, sustainability/energy-transition, and Canadian food-grower investments described on the firm's About page.
Check Size
No specific check-size range is published on the website. Disclosed round sizes Wittington has participated in span roughly $2M (Filament seed) to $78M (Arcaea Series A), but these reflect total round size across syndicates, not Wittington's individual check.
Lead Tendency
Mixed. Wittington has explicitly led rounds (Abridge Series A-1, alongside USV and Bessemer; WellBeam's $10M Series A; Filament's $2M seed) and co-led (Arcaea's $78M Series A, alongside Cascade Investment/Gates family office, Viking Global, Chanel, and Givaudan). It has also taken non-lead participant roles in syndicates led by others (Odaia's Series B led by Threshold Ventures and Monograph Capital; Doctronic's Series B alongside Abstract Ventures, Lightspeed, and Union Square Ventures; Noetik's Series A alongside Polaris Partners, DCVC, and Khosla Ventures; Brave's round alongside Town Hall Ventures, Union Square Ventures, City Light, and Able Partners).
Recent Activity
Wittington has been actively deploying through 2025 and 2026: it led Filament Sciences' $2M seed (Jun 2026), invested in ViewsML's round (Apr 2026), invested in Doctronic's $40M Series B (Mar 2026), invested in Shakudo (Feb 2026), and led WellBeam's $10M Series A (Nov 2025). Earlier notable deals include Noetik's $40M Series A (Aug 2024), Odaia's $25M Series B (May 2023), Unlearn's Series B-1 (Mar 2023), Brave's round (Oct 2022), Abridge's Series A-1 (Aug 2022), and Arcaea's $78M Series A (Oct 2021). The cadence and recency of 2025-2026 deals indicate an actively deploying fund.
Portfolio Highlights
Across climate, commerce, consumer, and healthcare, confirmed portfolio companies include: Abridge (ambient clinical AI documentation), Unlearn (AI patient digital twins for clinical trials), Remedy Meds/Thirty Madison (virtual health platform incorporating Nurx, Keeps, Cove), Courtyard (AI business-data platform for small businesses), Gatik (autonomous middle-mile trucking), Contentful (headless CMS), Brave Health (Medicaid-focused virtual mental health), Arcaea (synthetic-biology beauty ingredients, Ginkgo Bioworks spinout), Truvian (point-of-care blood testing device), Lemme (Kourtney Kardashian Barker wellness brand), Odaia (AI pharma sales enablement), Noetik (AI-driven cancer immunotherapy discovery), Divert (food-waste circular economy/RNG), TES Canada (green hydrogen and renewable fuels), USD Clean Fuels (low-carbon fuels infrastructure), Cosmetic Physician Partners (medical-aesthetics practice platform), Shakudo (enterprise AI operating system), Calico (AI-native apparel production platform), Filament Sciences (science-led haircare), ViewsML (AI virtual biomarker staining), Doctronic (AI clinical access layer), WellBeam (EHR-native post-acute care coordination), Par Olive (ingestible beauty), Form Health (virtual weight/cardiometabolic care), and Grey Matter (focused-ultrasound neurotech for Alzheimer's).
Team
- Jim Orlando, Managing Partner (Climate, Commerce, Consumer)
- Megh Gupta, Managing Partner (Healthcare)
- Qasim Mohammad, Partner (Commerce, Consumer)
- Zeeshan Ali, Partner (Climate, Healthcare)
- Jodi Kessler, Partner (Consumer)
- Zack Newton, Senior Director (Food)
- Austin Nalen Sprole, Director (Healthcare)
- Darian Zigante, Director (Climate, Commerce)
- Abigail Leung, Director (Climate)
- Leah Perry, Senior Associate (Climate, Healthcare)
- Eli Scott, Senior Associate (Commerce, Consumer)
- Tarek El Naggar, Associate (Commerce, Consumer)
- Leafy Feng, Associate (Climate)
- Christa Dickson, Executive Assistant
Decision Process
Not publicly disclosed in detail. The firm is organized as a sector-aligned partnership (two Managing Partners plus multiple Partners each owning specific verticals: climate, commerce, consumer, healthcare, food), which is most consistent with a partnership-style decision process rather than a solo GP.
Founder Preferences
Across its published investment write-ups, Wittington repeatedly backs founders with deep domain or scientific credibility paired with operating experience: a trained cardiologist and former digital-health investor (Shiv Rao, Abridge), PhD machine-learning researchers (Charles Fisher and team, Unlearn), a beauty-industry veteran who built brands at Fresh, Living Proof, and Mother Dirt (Jasmina Aganovic, Arcaea), a two-decade L'Oreal/Kiehl's executive (Nathan Puksta, Filament), and a consumer-product founder paired with a practicing clinician (Matt Pavelle and Dr. Adam Oskowitz, Doctronic). The pattern favors technical or clinical founder-market fit over generalist teams.
Geographic Focus
Primarily North America. The portfolio page states the firm invests in "technology-focused companies in North America," and confirmed portfolio companies are based in the US and Canada (including Toronto-headquartered Wittington itself and Vancouver-based ViewsML).